Skip to main content

Articles

Recent Articles

Cell & Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
Articles  —  22 December Dec 2021

Cell & Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC

Read More about Cell & Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study
Articles  —  22 December Dec 2021

Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study

Read More about Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study
Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
Articles  —  22 December Dec 2021

Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC

Read More about Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study
Articles  —  22 December Dec 2021

Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study

Read More about Programmatic Approach a Key to Completing Studies on Time and Budget - A Case Study
Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
Articles  —  22 December Dec 2021

Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC

Read More about Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC
GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer
Articles  —  21 December Dec 2021

GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer

Read More about GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer
GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer
Articles  —  21 December Dec 2021

GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer

Read More about GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer
Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards
Articles  —  14 December Dec 2021

Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards

Read More about Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards
Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards
Articles  —  14 December Dec 2021

Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards

Read More about Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards
PharmaVOICE Showcase and the Industry Dive
Articles  —  13 December Dec 2021

PharmaVOICE Showcase and the Industry Dive

Read More about PharmaVOICE Showcase and the Industry Dive
PharmaVOICE Showcase and the Industry Dive
Articles  —  13 December Dec 2021

PharmaVOICE Showcase and the Industry Dive

Read More about PharmaVOICE Showcase and the Industry Dive
Policy and Reimbursement Considerations in Early Clinical Development
Articles  —  10 December Dec 2021

Policy and Reimbursement Considerations in Early Clinical Development

Read More about Policy and Reimbursement Considerations in Early Clinical Development